By Manas Mishra and Julie Steenhuysen (Reuters) -A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday unanimously recommended use of...
BERLIN (Reuters) -A booster dose of the COVID-19 vaccine developed by Pfizer Inc (NYSE:PFE) and German partner BioNTech SE (NASDAQ:BNTX) restored efficacy to 95.6% against the...
(Reuters) - The United States has administered 411,010,650 doses of COVID-19 vaccines in the country as of Thursday morning and distributed 498,702,405 doses, the U.S. Centers for...
FDA Approves Moderna, J&J Boosters And Releases Guidelines For "Mix And Match"In defiance of recommendations from its own advisory panel, which said last week that the Moderna jab...
S&P 500 futures flat after index nears recordStrong earnings from Nestle and DeliverooBitcoin soarsKey FinancialsEquity market attempts to price in solid earnings against a...
The ProShares Bitcoin Strategy ETF (NYSE:BITO), the first Bitcoin ETF was issued Tuesday morning. The ETF provides retail investors their first true access to Bitcoin without...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Sell | Buy | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 149.48 | 149.64 | 147.87 | +0.22 | +0.15% | 60.91M | NASDAQ | |||
| 2,837.70 | 2,843.10 | 2,810.00 | +2.3 | +0.08% | 1.12M | NASDAQ | |||
| 341.88 | 342.31 | 337.80 | +1.10 | +0.32% | 11.32M | NASDAQ | |||
| 56.00 | 56.07 | 54.83 | +0.63 | +1.14% | 33.00M | NASDAQ | |||
| 75.11 | 75.95 | 73.89 | -0.54 | -0.71% | 23.11M | NYSE | |||
| 243.21 | 258.96 | 242.98 | -15.15 | -5.86% | 42.03M | NASDAQ | |||
| 11.30 | 11.91 | 11.15 | -0.11 | -0.96% | 13.10M | NYSE | |||
| 25.76 | 26.29 | 25.60 | -0.15 | -0.58% | 55.41M | NYSE | |||
| 26.17 | 26.46 | 25.24 | +1.26 | +5.06% | 274.97K | NYSE | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 128.33 | 133.72 | 128.10 | -13.57 | -9.56% | 31.33M | NYSE | |||
| 19.37 | 19.43 | 19.21 | -0.05 | -0.26% | 9.81M | NYSE | |||
| 12.97 | 13.07 | 12.67 | +0.12 | +0.93% | 3.00M | NYSE | |||
| 1.88 | 1.97 | 1.84 | -0.0800 | -4.08% | 13.09M | NYSE | |||
| 0.4393 | 0.00 | 0.00 | -0.0092 | -2.05% | 1.84M | NYSE |
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.